nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Pentagastrin—CCKBR—pancreatic cancer	0.0152	0.54	CrCbGaD
Goserelin—Ceruletide—CCKAR—pancreatic cancer	0.0129	0.46	CrCbGaD
Goserelin—GNRHR—GPCR ligand binding—CCKAR—pancreatic cancer	0.000969	0.00264	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GAST—pancreatic cancer	0.000944	0.00257	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000928	0.00253	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—SCT—pancreatic cancer	0.000895	0.00244	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—SHH—pancreatic cancer	0.000884	0.00241	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRLHR—pancreatic cancer	0.00088	0.0024	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—IAPP—pancreatic cancer	0.000873	0.00238	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GAST—pancreatic cancer	0.000857	0.00233	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000855	0.00233	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCK—pancreatic cancer	0.000853	0.00233	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTHLH—pancreatic cancer	0.000838	0.00228	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTCH1—pancreatic cancer	0.000838	0.00228	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CNR2—pancreatic cancer	0.000832	0.00227	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000832	0.00227	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000824	0.00225	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000818	0.00223	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SCT—pancreatic cancer	0.000812	0.00221	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GDI1—pancreatic cancer	0.000807	0.0022	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GDI2—pancreatic cancer	0.000807	0.0022	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00079	0.00215	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRLHR—pancreatic cancer	0.000777	0.00212	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCK—pancreatic cancer	0.000775	0.00211	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PPY—pancreatic cancer	0.000775	0.00211	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—SST—pancreatic cancer	0.000766	0.00209	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000761	0.00207	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR2—pancreatic cancer	0.000755	0.00206	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GLP1R—pancreatic cancer	0.000755	0.00206	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SSTR3—pancreatic cancer	0.000748	0.00204	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCKAR—pancreatic cancer	0.000743	0.00202	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IAPP—pancreatic cancer	0.000737	0.00201	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000735	0.002	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ZNRF3—pancreatic cancer	0.00073	0.00199	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ACVR1B—pancreatic cancer	0.00073	0.00199	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SSTR1—pancreatic cancer	0.000718	0.00196	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000707	0.00193	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CNR1—pancreatic cancer	0.000707	0.00193	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PPY—pancreatic cancer	0.000704	0.00192	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SSTR2—pancreatic cancer	0.000691	0.00188	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GCG—pancreatic cancer	0.000683	0.00186	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SHH—pancreatic cancer	0.000677	0.00185	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IAPP—pancreatic cancer	0.000669	0.00182	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCKBR—pancreatic cancer	0.000667	0.00182	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SSTR3—pancreatic cancer	0.00066	0.0018	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DTX1—pancreatic cancer	0.00066	0.0018	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AGTR1—pancreatic cancer	0.000651	0.00178	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—SST—pancreatic cancer	0.000647	0.00176	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTHLH—pancreatic cancer	0.000642	0.00175	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTCH1—pancreatic cancer	0.000642	0.00175	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SSTR1—pancreatic cancer	0.000633	0.00173	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GAST—pancreatic cancer	0.000632	0.00172	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PPY—pancreatic cancer	0.000621	0.00169	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SSTR2—pancreatic cancer	0.00061	0.00166	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SCT—pancreatic cancer	0.000599	0.00163	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CNR1—pancreatic cancer	0.000597	0.00163	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCKBR—pancreatic cancer	0.000589	0.0016	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—SST—pancreatic cancer	0.000587	0.0016	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000585	0.0016	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GCG—pancreatic cancer	0.000576	0.00157	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GAST—pancreatic cancer	0.000574	0.00156	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCK—pancreatic cancer	0.000571	0.00156	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000557	0.00152	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR2—pancreatic cancer	0.000557	0.00152	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GLI1—pancreatic cancer	0.000553	0.00151	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DTX4—pancreatic cancer	0.000553	0.00151	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.00055	0.0015	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000548	0.00149	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SCT—pancreatic cancer	0.000544	0.00148	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR1—pancreatic cancer	0.000542	0.00148	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NRP1—pancreatic cancer	0.000538	0.00147	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000538	0.00147	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GCG—pancreatic cancer	0.000523	0.00143	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRLHR—pancreatic cancer	0.00052	0.00142	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCK—pancreatic cancer	0.000519	0.00141	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HEY2—pancreatic cancer	0.000518	0.00141	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GAST—pancreatic cancer	0.000506	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR2—pancreatic cancer	0.000506	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GLP1R—pancreatic cancer	0.000506	0.00138	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000499	0.00136	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCKAR—pancreatic cancer	0.000497	0.00136	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IAPP—pancreatic cancer	0.000493	0.00134	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ZNRF3—pancreatic cancer	0.000489	0.00133	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ACVR1B—pancreatic cancer	0.000489	0.00133	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SCT—pancreatic cancer	0.00048	0.00131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HEY1—pancreatic cancer	0.00048	0.00131	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000473	0.00129	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCK—pancreatic cancer	0.000458	0.00125	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SHH—pancreatic cancer	0.000453	0.00124	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IAPP—pancreatic cancer	0.000448	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR2—pancreatic cancer	0.000446	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GLP1R—pancreatic cancer	0.000446	0.00122	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000446	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DTX1—pancreatic cancer	0.000442	0.0012	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR3—pancreatic cancer	0.000442	0.0012	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCKAR—pancreatic cancer	0.000439	0.0012	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—SST—pancreatic cancer	0.000433	0.00118	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTHLH—pancreatic cancer	0.00043	0.00117	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTCH1—pancreatic cancer	0.00043	0.00117	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAG2—pancreatic cancer	0.000426	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000425	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR1—pancreatic cancer	0.000424	0.00116	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MEN1—pancreatic cancer	0.000419	0.00114	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPY—pancreatic cancer	0.000416	0.00113	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SSTR2—pancreatic cancer	0.000408	0.00111	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SHH—pancreatic cancer	0.0004	0.00109	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR1—pancreatic cancer	0.0004	0.00109	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000398	0.00108	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IAPP—pancreatic cancer	0.000395	0.00108	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCKBR—pancreatic cancer	0.000394	0.00107	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SST—pancreatic cancer	0.000393	0.00107	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000392	0.00107	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000387	0.00105	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GCG—pancreatic cancer	0.000386	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTHLH—pancreatic cancer	0.000379	0.00103	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTCH1—pancreatic cancer	0.000379	0.00103	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000375	0.00102	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DTX4—pancreatic cancer	0.000371	0.00101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLI1—pancreatic cancer	0.000371	0.00101	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000368	0.001	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000365	0.000996	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR1—pancreatic cancer	0.000363	0.000989	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRP1—pancreatic cancer	0.00036	0.000982	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00036	0.000982	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GCG—pancreatic cancer	0.00035	0.000955	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HEY2—pancreatic cancer	0.000347	0.000945	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SST—pancreatic cancer	0.000347	0.000945	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000342	0.000932	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAG1—pancreatic cancer	0.00034	0.000925	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GAST—pancreatic cancer	0.000339	0.000923	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000338	0.000921	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000336	0.000915	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGTR1—pancreatic cancer	0.000334	0.000911	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SCT—pancreatic cancer	0.000321	0.000875	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HEY1—pancreatic cancer	0.000321	0.000875	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR1—pancreatic cancer	0.00032	0.000872	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000311	0.000847	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000311	0.000846	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GCG—pancreatic cancer	0.000309	0.000843	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCK—pancreatic cancer	0.000306	0.000835	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000301	0.00082	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CNR2—pancreatic cancer	0.000299	0.000814	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLP1R—pancreatic cancer	0.000299	0.000814	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—pancreatic cancer	0.000298	0.000813	CbGpPWpGaD
Goserelin—Weight increased—Epirubicin—pancreatic cancer	0.000296	0.000489	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—AGTR1—pancreatic cancer	0.000295	0.000804	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCKAR—pancreatic cancer	0.000294	0.000801	CbGpPWpGaD
Goserelin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000293	0.000484	CcSEcCtD
Goserelin—Cough—Docetaxel—pancreatic cancer	0.000293	0.000484	CcSEcCtD
Goserelin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000293	0.000484	CcSEcCtD
Goserelin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000292	0.000483	CcSEcCtD
Goserelin—Pneumonia—Epirubicin—pancreatic cancer	0.000291	0.000482	CcSEcCtD
Goserelin—Convulsion—Docetaxel—pancreatic cancer	0.000291	0.000481	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—STK11—pancreatic cancer	0.000291	0.000792	CbGpPWpGaD
Goserelin—Hypertension—Docetaxel—pancreatic cancer	0.00029	0.000479	CcSEcCtD
Goserelin—Drowsiness—Epirubicin—pancreatic cancer	0.00029	0.000479	CcSEcCtD
Goserelin—Bronchitis—Doxorubicin—pancreatic cancer	0.000289	0.000478	CcSEcCtD
Goserelin—Chest pain—Docetaxel—pancreatic cancer	0.000286	0.000472	CcSEcCtD
Goserelin—Myalgia—Docetaxel—pancreatic cancer	0.000286	0.000472	CcSEcCtD
Goserelin—Arthralgia—Docetaxel—pancreatic cancer	0.000286	0.000472	CcSEcCtD
Goserelin—Nausea—Sunitinib—pancreatic cancer	0.000286	0.000472	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—JAG2—pancreatic cancer	0.000285	0.000776	CbGpPWpGaD
Goserelin—Renal failure—Epirubicin—pancreatic cancer	0.000285	0.000471	CcSEcCtD
Goserelin—Asthenia—Irinotecan—pancreatic cancer	0.000284	0.00047	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000284	0.000469	CcSEcCtD
Goserelin—Jaundice—Epirubicin—pancreatic cancer	0.000282	0.000467	CcSEcCtD
Goserelin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000282	0.000465	CcSEcCtD
Goserelin—Dysuria—Doxorubicin—pancreatic cancer	0.000281	0.000465	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—MEN1—pancreatic cancer	0.000281	0.000765	CbGpPWpGaD
Goserelin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00028	0.000462	CcSEcCtD
Goserelin—Dry mouth—Docetaxel—pancreatic cancer	0.000279	0.000462	CcSEcCtD
Goserelin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000279	0.000462	CcSEcCtD
Goserelin—Sweating—Epirubicin—pancreatic cancer	0.000278	0.000459	CcSEcCtD
Goserelin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000278	0.000459	CcSEcCtD
Goserelin—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.000458	CcSEcCtD
Goserelin—Haematuria—Epirubicin—pancreatic cancer	0.000276	0.000457	CcSEcCtD
Goserelin—Confusional state—Docetaxel—pancreatic cancer	0.000276	0.000457	CcSEcCtD
Goserelin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000274	0.000454	CcSEcCtD
Goserelin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000274	0.000453	CcSEcCtD
Goserelin—Oedema—Docetaxel—pancreatic cancer	0.000274	0.000453	CcSEcCtD
Goserelin—Weight increased—Doxorubicin—pancreatic cancer	0.000274	0.000452	CcSEcCtD
Goserelin—Epistaxis—Epirubicin—pancreatic cancer	0.000273	0.000452	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000273	0.000744	CbGpPWpGaD
Goserelin—Pruritus—Gemcitabine—pancreatic cancer	0.000273	0.000451	CcSEcCtD
Goserelin—Infection—Docetaxel—pancreatic cancer	0.000272	0.00045	CcSEcCtD
Goserelin—Sinusitis—Epirubicin—pancreatic cancer	0.000272	0.000449	CcSEcCtD
Goserelin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000271	0.000448	CcSEcCtD
Goserelin—Diarrhoea—Irinotecan—pancreatic cancer	0.000271	0.000448	CcSEcCtD
Goserelin—Pneumonia—Doxorubicin—pancreatic cancer	0.00027	0.000446	CcSEcCtD
Goserelin—Shock—Docetaxel—pancreatic cancer	0.000269	0.000445	CcSEcCtD
Goserelin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000269	0.000444	CcSEcCtD
Goserelin—Pruritus—Fluorouracil—pancreatic cancer	0.000268	0.000444	CcSEcCtD
Goserelin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000268	0.000443	CcSEcCtD
Goserelin—Drowsiness—Doxorubicin—pancreatic cancer	0.000268	0.000443	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SHH—pancreatic cancer	0.000268	0.00073	CbGpPWpGaD
Goserelin—Tachycardia—Docetaxel—pancreatic cancer	0.000267	0.000442	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NOTCH4—pancreatic cancer	0.000266	0.000725	CbGpPWpGaD
Goserelin—Skin disorder—Docetaxel—pancreatic cancer	0.000266	0.00044	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IAPP—pancreatic cancer	0.000265	0.000721	CbGpPWpGaD
Goserelin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000264	0.000437	CcSEcCtD
Goserelin—Renal failure—Doxorubicin—pancreatic cancer	0.000263	0.000436	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000262	0.000714	CbGpPWpGaD
Goserelin—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.000433	CcSEcCtD
Goserelin—Haemoglobin—Epirubicin—pancreatic cancer	0.000261	0.000432	CcSEcCtD
Goserelin—Jaundice—Doxorubicin—pancreatic cancer	0.000261	0.000432	CcSEcCtD
Goserelin—Anorexia—Docetaxel—pancreatic cancer	0.000261	0.000432	CcSEcCtD
Goserelin—Rhinitis—Epirubicin—pancreatic cancer	0.000261	0.000431	CcSEcCtD
Goserelin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000261	0.000431	CcSEcCtD
Goserelin—Haemorrhage—Epirubicin—pancreatic cancer	0.00026	0.00043	CcSEcCtD
Goserelin—Hepatitis—Epirubicin—pancreatic cancer	0.00026	0.00043	CcSEcCtD
Goserelin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00026	0.000429	CcSEcCtD
Goserelin—Pharyngitis—Epirubicin—pancreatic cancer	0.000258	0.000427	CcSEcCtD
Goserelin—Sweating—Doxorubicin—pancreatic cancer	0.000257	0.000425	CcSEcCtD
Goserelin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000257	0.000425	CcSEcCtD
Goserelin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000256	0.000423	CcSEcCtD
Goserelin—Hypotension—Docetaxel—pancreatic cancer	0.000256	0.000423	CcSEcCtD
Goserelin—Haematuria—Doxorubicin—pancreatic cancer	0.000256	0.000422	CcSEcCtD
Goserelin—Urethral disorder—Epirubicin—pancreatic cancer	0.000255	0.000421	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SMAD4—pancreatic cancer	0.000255	0.000694	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTHLH—pancreatic cancer	0.000254	0.000692	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTCH1—pancreatic cancer	0.000254	0.000692	CbGpPWpGaD
Goserelin—Epistaxis—Doxorubicin—pancreatic cancer	0.000253	0.000418	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000252	0.000687	CbGpPWpGaD
Goserelin—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000416	CcSEcCtD
Goserelin—Sinusitis—Doxorubicin—pancreatic cancer	0.000251	0.000416	CcSEcCtD
Goserelin—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000415	CcSEcCtD
Goserelin—Rash—Irinotecan—pancreatic cancer	0.00025	0.000413	CcSEcCtD
Goserelin—Dermatitis—Irinotecan—pancreatic cancer	0.00025	0.000413	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00025	0.000413	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HES1—pancreatic cancer	0.000249	0.000677	CbGpPWpGaD
Goserelin—Headache—Irinotecan—pancreatic cancer	0.000248	0.00041	CcSEcCtD
Goserelin—Insomnia—Docetaxel—pancreatic cancer	0.000248	0.00041	CcSEcCtD
Goserelin—Paraesthesia—Docetaxel—pancreatic cancer	0.000246	0.000407	CcSEcCtD
Goserelin—Vomiting—Gemcitabine—pancreatic cancer	0.000245	0.000406	CcSEcCtD
Goserelin—Dyspnoea—Docetaxel—pancreatic cancer	0.000244	0.000404	CcSEcCtD
Goserelin—Somnolence—Docetaxel—pancreatic cancer	0.000243	0.000403	CcSEcCtD
Goserelin—Rash—Gemcitabine—pancreatic cancer	0.000243	0.000402	CcSEcCtD
Goserelin—Dermatitis—Gemcitabine—pancreatic cancer	0.000243	0.000402	CcSEcCtD
Goserelin—Eye disorder—Epirubicin—pancreatic cancer	0.000243	0.000402	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000242	0.0004	CcSEcCtD
Goserelin—Headache—Gemcitabine—pancreatic cancer	0.000242	0.0004	CcSEcCtD
Goserelin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000241	0.000399	CcSEcCtD
Goserelin—Vomiting—Fluorouracil—pancreatic cancer	0.000241	0.000399	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—pancreatic cancer	0.000241	0.000399	CcSEcCtD
Goserelin—Dyspepsia—Docetaxel—pancreatic cancer	0.000241	0.000399	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000241	0.000398	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—pancreatic cancer	0.000241	0.000398	CcSEcCtD
Goserelin—Rash—Fluorouracil—pancreatic cancer	0.000239	0.000396	CcSEcCtD
Goserelin—Dermatitis—Fluorouracil—pancreatic cancer	0.000239	0.000395	CcSEcCtD
Goserelin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000239	0.000395	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000238	0.000649	CbGpPWpGaD
Goserelin—Decreased appetite—Docetaxel—pancreatic cancer	0.000238	0.000394	CcSEcCtD
Goserelin—Headache—Fluorouracil—pancreatic cancer	0.000238	0.000393	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000238	0.000393	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000237	0.000392	CcSEcCtD
Goserelin—Fatigue—Docetaxel—pancreatic cancer	0.000236	0.00039	CcSEcCtD
Goserelin—Angiopathy—Epirubicin—pancreatic cancer	0.000236	0.00039	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000236	0.00039	CcSEcCtD
Goserelin—Nausea—Irinotecan—pancreatic cancer	0.000235	0.000389	CcSEcCtD
Goserelin—Immune system disorder—Epirubicin—pancreatic cancer	0.000235	0.000388	CcSEcCtD
Goserelin—Constipation—Docetaxel—pancreatic cancer	0.000234	0.000387	CcSEcCtD
Goserelin—Pain—Docetaxel—pancreatic cancer	0.000234	0.000387	CcSEcCtD
Goserelin—Chills—Epirubicin—pancreatic cancer	0.000233	0.000386	CcSEcCtD
Goserelin—Arrhythmia—Epirubicin—pancreatic cancer	0.000232	0.000384	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SST—pancreatic cancer	0.000232	0.000633	CbGpPWpGaD
Goserelin—Alopecia—Epirubicin—pancreatic cancer	0.00023	0.00038	CcSEcCtD
Goserelin—Nausea—Gemcitabine—pancreatic cancer	0.000229	0.000379	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000229	0.000624	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—pancreatic cancer	0.000229	0.000623	CbGpPWpGaD
Goserelin—Mental disorder—Epirubicin—pancreatic cancer	0.000228	0.000377	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—JAG1—pancreatic cancer	0.000227	0.000619	CbGpPWpGaD
Goserelin—Erythema—Epirubicin—pancreatic cancer	0.000226	0.000374	CcSEcCtD
Goserelin—Malnutrition—Epirubicin—pancreatic cancer	0.000226	0.000374	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NOTCH3—pancreatic cancer	0.000226	0.000617	CbGpPWpGaD
Goserelin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000226	0.000373	CcSEcCtD
Goserelin—Nausea—Fluorouracil—pancreatic cancer	0.000225	0.000373	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—pancreatic cancer	0.000225	0.000372	CcSEcCtD
Goserelin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.00037	CcSEcCtD
Goserelin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000223	0.000369	CcSEcCtD
Goserelin—Flatulence—Epirubicin—pancreatic cancer	0.000223	0.000369	CcSEcCtD
Goserelin—Tension—Epirubicin—pancreatic cancer	0.000222	0.000367	CcSEcCtD
Goserelin—Nervousness—Epirubicin—pancreatic cancer	0.00022	0.000363	CcSEcCtD
Goserelin—Back pain—Epirubicin—pancreatic cancer	0.000219	0.000362	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—pancreatic cancer	0.000218	0.000361	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—TERT—pancreatic cancer	0.000218	0.000594	CbGpPWpGaD
Goserelin—Muscle spasms—Epirubicin—pancreatic cancer	0.000218	0.00036	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000217	0.000359	CcSEcCtD
Goserelin—Body temperature increased—Docetaxel—pancreatic cancer	0.000217	0.000358	CcSEcCtD
Goserelin—Abdominal pain—Docetaxel—pancreatic cancer	0.000217	0.000358	CcSEcCtD
Goserelin—Chills—Doxorubicin—pancreatic cancer	0.000216	0.000357	CcSEcCtD
Goserelin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000215	0.000355	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CNR1—pancreatic cancer	0.000214	0.000584	CbGpPWpGaD
Goserelin—Vision blurred—Epirubicin—pancreatic cancer	0.000213	0.000353	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—pancreatic cancer	0.000213	0.000351	CcSEcCtD
Goserelin—Mental disorder—Doxorubicin—pancreatic cancer	0.000211	0.000348	CcSEcCtD
Goserelin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00021	0.000347	CcSEcCtD
Goserelin—Malnutrition—Doxorubicin—pancreatic cancer	0.000209	0.000346	CcSEcCtD
Goserelin—Erythema—Doxorubicin—pancreatic cancer	0.000209	0.000346	CcSEcCtD
Goserelin—Anaemia—Epirubicin—pancreatic cancer	0.000209	0.000346	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HIF1A—pancreatic cancer	0.000208	0.000568	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000208	0.000567	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TSC2—pancreatic cancer	0.000208	0.000566	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GCG—pancreatic cancer	0.000207	0.000564	CbGpPWpGaD
Goserelin—Flatulence—Doxorubicin—pancreatic cancer	0.000206	0.000341	CcSEcCtD
Goserelin—Tension—Doxorubicin—pancreatic cancer	0.000206	0.00034	CcSEcCtD
Goserelin—Malaise—Epirubicin—pancreatic cancer	0.000204	0.000337	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—pancreatic cancer	0.000203	0.000336	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOE—pancreatic cancer	0.000203	0.000554	CbGpPWpGaD
Goserelin—Leukopenia—Epirubicin—pancreatic cancer	0.000203	0.000335	CcSEcCtD
Goserelin—Back pain—Doxorubicin—pancreatic cancer	0.000203	0.000335	CcSEcCtD
Goserelin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000202	0.000334	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000201	0.000549	CbGpPWpGaD
Goserelin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000201	0.000333	CcSEcCtD
Goserelin—Palpitations—Epirubicin—pancreatic cancer	0.0002	0.000331	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—KDR—pancreatic cancer	0.000199	0.000543	CbGpPWpGaD
Goserelin—Cough—Epirubicin—pancreatic cancer	0.000198	0.000327	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AGTR1—pancreatic cancer	0.000197	0.000538	CbGpPWpGaD
Goserelin—Vision blurred—Doxorubicin—pancreatic cancer	0.000197	0.000326	CcSEcCtD
Goserelin—Asthenia—Docetaxel—pancreatic cancer	0.000197	0.000325	CcSEcCtD
Goserelin—Convulsion—Epirubicin—pancreatic cancer	0.000196	0.000324	CcSEcCtD
Goserelin—Hypertension—Epirubicin—pancreatic cancer	0.000195	0.000323	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—STK11—pancreatic cancer	0.000195	0.00053	CbGpPWpGaD
Goserelin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000194	0.000321	CcSEcCtD
Goserelin—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.00032	CcSEcCtD
Goserelin—Anaemia—Doxorubicin—pancreatic cancer	0.000194	0.00032	CcSEcCtD
Goserelin—Chest pain—Epirubicin—pancreatic cancer	0.000193	0.000319	CcSEcCtD
Goserelin—Arthralgia—Epirubicin—pancreatic cancer	0.000193	0.000319	CcSEcCtD
Goserelin—Myalgia—Epirubicin—pancreatic cancer	0.000193	0.000319	CcSEcCtD
Goserelin—Anxiety—Epirubicin—pancreatic cancer	0.000192	0.000317	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000191	0.000316	CcSEcCtD
Goserelin—Discomfort—Epirubicin—pancreatic cancer	0.00019	0.000315	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NFKBIA—pancreatic cancer	0.00019	0.000516	CbGpPWpGaD
Goserelin—Malaise—Doxorubicin—pancreatic cancer	0.000189	0.000312	CcSEcCtD
Goserelin—Dry mouth—Epirubicin—pancreatic cancer	0.000188	0.000312	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000188	0.000511	CbGpPWpGaD
Goserelin—Leukopenia—Doxorubicin—pancreatic cancer	0.000187	0.00031	CcSEcCtD
Goserelin—Diarrhoea—Docetaxel—pancreatic cancer	0.000187	0.00031	CcSEcCtD
Goserelin—Confusional state—Epirubicin—pancreatic cancer	0.000186	0.000308	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—pancreatic cancer	0.000185	0.000306	CcSEcCtD
Goserelin—Oedema—Epirubicin—pancreatic cancer	0.000185	0.000305	CcSEcCtD
Goserelin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000185	0.000305	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000184	0.0005	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NRAS—pancreatic cancer	0.000184	0.0005	CbGpPWpGaD
Goserelin—Infection—Epirubicin—pancreatic cancer	0.000184	0.000303	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000183	0.000498	CbGpPWpGaD
Goserelin—Cough—Doxorubicin—pancreatic cancer	0.000183	0.000302	CcSEcCtD
Goserelin—Shock—Epirubicin—pancreatic cancer	0.000182	0.0003	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—pancreatic cancer	0.000181	0.0003	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—EGF—pancreatic cancer	0.000181	0.000494	CbGpPWpGaD
Goserelin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000181	0.000299	CcSEcCtD
Goserelin—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.000299	CcSEcCtD
Goserelin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000181	0.000299	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—pancreatic cancer	0.000181	0.000299	CcSEcCtD
Goserelin—Tachycardia—Epirubicin—pancreatic cancer	0.00018	0.000298	CcSEcCtD
Goserelin—Skin disorder—Epirubicin—pancreatic cancer	0.000179	0.000297	CcSEcCtD
Goserelin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000179	0.000295	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—pancreatic cancer	0.000178	0.000295	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—pancreatic cancer	0.000178	0.000295	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—pancreatic cancer	0.000178	0.000295	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—pancreatic cancer	0.000178	0.000294	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000177	0.000293	CcSEcCtD
Goserelin—Discomfort—Doxorubicin—pancreatic cancer	0.000176	0.000291	CcSEcCtD
Goserelin—Anorexia—Epirubicin—pancreatic cancer	0.000176	0.000291	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000176	0.000478	CbGpPWpGaD
Goserelin—Dry mouth—Doxorubicin—pancreatic cancer	0.000174	0.000288	CcSEcCtD
Goserelin—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.000288	CcSEcCtD
Goserelin—Rash—Docetaxel—pancreatic cancer	0.000173	0.000285	CcSEcCtD
Goserelin—Hypotension—Epirubicin—pancreatic cancer	0.000173	0.000285	CcSEcCtD
Goserelin—Dermatitis—Docetaxel—pancreatic cancer	0.000173	0.000285	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—pancreatic cancer	0.000172	0.000285	CcSEcCtD
Goserelin—Headache—Docetaxel—pancreatic cancer	0.000172	0.000284	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000171	0.000283	CcSEcCtD
Goserelin—Oedema—Doxorubicin—pancreatic cancer	0.000171	0.000283	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—SMAD4—pancreatic cancer	0.00017	0.000465	CbGpPWpGaD
Goserelin—Infection—Doxorubicin—pancreatic cancer	0.00017	0.000281	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000169	0.00046	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000168	0.000278	CcSEcCtD
Goserelin—Shock—Doxorubicin—pancreatic cancer	0.000168	0.000278	CcSEcCtD
Goserelin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000168	0.000277	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000167	0.000277	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—EGFR—pancreatic cancer	0.000167	0.000456	CbGpPWpGaD
Goserelin—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000276	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—pancreatic cancer	0.000167	0.000276	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HES1—pancreatic cancer	0.000166	0.000454	CbGpPWpGaD
Goserelin—Skin disorder—Doxorubicin—pancreatic cancer	0.000166	0.000274	CcSEcCtD
Goserelin—Paraesthesia—Epirubicin—pancreatic cancer	0.000166	0.000274	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000165	0.000273	CcSEcCtD
Goserelin—Dyspnoea—Epirubicin—pancreatic cancer	0.000165	0.000272	CcSEcCtD
Goserelin—Somnolence—Epirubicin—pancreatic cancer	0.000164	0.000271	CcSEcCtD
Goserelin—Anorexia—Doxorubicin—pancreatic cancer	0.000163	0.000269	CcSEcCtD
Goserelin—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000269	CcSEcCtD
Goserelin—Dyspepsia—Epirubicin—pancreatic cancer	0.000163	0.000269	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000161	0.00044	CbGpPWpGaD
Goserelin—Decreased appetite—Epirubicin—pancreatic cancer	0.000161	0.000265	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.00016	0.000436	CbGpPWpGaD
Goserelin—Hypotension—Doxorubicin—pancreatic cancer	0.00016	0.000264	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000159	0.000434	CbGpPWpGaD
Goserelin—Fatigue—Epirubicin—pancreatic cancer	0.000159	0.000263	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—KRAS—pancreatic cancer	0.000158	0.00043	CbGpPWpGaD
Goserelin—Constipation—Epirubicin—pancreatic cancer	0.000158	0.000261	CcSEcCtD
Goserelin—Pain—Epirubicin—pancreatic cancer	0.000158	0.000261	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.000257	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—pancreatic cancer	0.000155	0.000256	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000153	0.000254	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—pancreatic cancer	0.000153	0.000417	CbGpPWpGaD
Goserelin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000152	0.000252	CcSEcCtD
Goserelin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000152	0.000252	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—pancreatic cancer	0.000152	0.000251	CcSEcCtD
Goserelin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.00025	CcSEcCtD
Goserelin—Dyspepsia—Doxorubicin—pancreatic cancer	0.00015	0.000249	CcSEcCtD
Goserelin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000149	0.000246	CcSEcCtD
Goserelin—Fatigue—Doxorubicin—pancreatic cancer	0.000147	0.000244	CcSEcCtD
Goserelin—Urticaria—Epirubicin—pancreatic cancer	0.000147	0.000243	CcSEcCtD
Goserelin—Constipation—Doxorubicin—pancreatic cancer	0.000146	0.000242	CcSEcCtD
Goserelin—Pain—Doxorubicin—pancreatic cancer	0.000146	0.000242	CcSEcCtD
Goserelin—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.000241	CcSEcCtD
Goserelin—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.000241	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—TERT—pancreatic cancer	0.000146	0.000397	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000145	0.000396	CbGpPWpGaD
Goserelin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.000233	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PIK3CB—pancreatic cancer	0.000141	0.000383	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000231	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HIF1A—pancreatic cancer	0.000139	0.00038	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TSC2—pancreatic cancer	0.000139	0.000379	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—pancreatic cancer	0.000136	0.000371	CbGpPWpGaD
Goserelin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000225	CcSEcCtD
Goserelin—Urticaria—Doxorubicin—pancreatic cancer	0.000136	0.000224	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CXCL8—pancreatic cancer	0.000135	0.000368	CbGpPWpGaD
Goserelin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.000223	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.000223	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—HRAS—pancreatic cancer	0.000134	0.000366	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—pancreatic cancer	0.000133	0.000363	CbGpPWpGaD
Goserelin—Asthenia—Epirubicin—pancreatic cancer	0.000133	0.000219	CcSEcCtD
Goserelin—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.000216	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—pancreatic cancer	0.000131	0.000356	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—pancreatic cancer	0.000129	0.000353	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NFKBIA—pancreatic cancer	0.000127	0.000346	CbGpPWpGaD
Goserelin—Diarrhoea—Epirubicin—pancreatic cancer	0.000126	0.000209	CcSEcCtD
Goserelin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000126	0.000208	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCND1—pancreatic cancer	0.000126	0.000343	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH1—pancreatic cancer	0.000126	0.000342	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CTNNB1—pancreatic cancer	0.000125	0.00034	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—pancreatic cancer	0.000123	0.000335	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NRAS—pancreatic cancer	0.000123	0.000335	CbGpPWpGaD
Goserelin—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000203	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MMP9—pancreatic cancer	0.000122	0.000333	CbGpPWpGaD
Goserelin—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000202	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PTEN—pancreatic cancer	0.000122	0.000331	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGF—pancreatic cancer	0.000121	0.000331	CbGpPWpGaD
Goserelin—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.0002	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AKT1—pancreatic cancer	0.000119	0.000323	CbGpPWpGaD
Goserelin—Vomiting—Epirubicin—pancreatic cancer	0.000117	0.000194	CcSEcCtD
Goserelin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.000193	CcSEcCtD
Goserelin—Rash—Epirubicin—pancreatic cancer	0.000116	0.000193	CcSEcCtD
Goserelin—Dermatitis—Epirubicin—pancreatic cancer	0.000116	0.000192	CcSEcCtD
Goserelin—Headache—Epirubicin—pancreatic cancer	0.000116	0.000191	CcSEcCtD
Goserelin—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000187	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SRC—pancreatic cancer	0.000113	0.000307	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—pancreatic cancer	0.000112	0.000305	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—pancreatic cancer	0.00011	0.000299	CbGpPWpGaD
Goserelin—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000181	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—STAT3—pancreatic cancer	0.000109	0.000296	CbGpPWpGaD
Goserelin—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.00018	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NRAS—pancreatic cancer	0.000108	0.000295	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CD—pancreatic cancer	0.000108	0.000294	CbGpPWpGaD
Goserelin—Rash—Doxorubicin—pancreatic cancer	0.000108	0.000178	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—pancreatic cancer	0.000108	0.000178	CcSEcCtD
Goserelin—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000177	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000107	0.000292	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—pancreatic cancer	0.000106	0.000288	CbGpPWpGaD
Goserelin—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000168	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MYC—pancreatic cancer	0.000101	0.000275	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—pancreatic cancer	0.000101	0.000275	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—pancreatic cancer	9.88e-05	0.000269	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—pancreatic cancer	9.72e-05	0.000265	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CB—pancreatic cancer	9.42e-05	0.000257	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—pancreatic cancer	9.33e-05	0.000254	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—pancreatic cancer	9.05e-05	0.000247	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRAS—pancreatic cancer	8.99e-05	0.000245	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—pancreatic cancer	8.74e-05	0.000238	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—pancreatic cancer	8.66e-05	0.000236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—pancreatic cancer	8.57e-05	0.000234	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—pancreatic cancer	8.43e-05	0.00023	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CTNNB1—pancreatic cancer	8.35e-05	0.000227	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—pancreatic cancer	8.29e-05	0.000226	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—pancreatic cancer	8.18e-05	0.000223	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTEN—pancreatic cancer	8.14e-05	0.000222	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—pancreatic cancer	7.94e-05	0.000216	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—pancreatic cancer	7.93e-05	0.000216	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SRC—pancreatic cancer	7.55e-05	0.000206	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—pancreatic cancer	7.35e-05	0.0002	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—pancreatic cancer	7.28e-05	0.000198	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRAS—pancreatic cancer	7.26e-05	0.000198	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—pancreatic cancer	7e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—pancreatic cancer	6.76e-05	0.000184	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—pancreatic cancer	6.75e-05	0.000184	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—pancreatic cancer	6.61e-05	0.00018	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—pancreatic cancer	6.25e-05	0.00017	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—pancreatic cancer	5.74e-05	0.000156	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—pancreatic cancer	5.55e-05	0.000151	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—pancreatic cancer	5.31e-05	0.000145	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—pancreatic cancer	4.69e-05	0.000128	CbGpPWpGaD
